Jigar Raythatha - Sep 13, 2021 Form 3 Insider Report for Jounce Therapeutics, Inc. (JNCE)

Role
Director
Signature
/s/ Elizabeth Shortsleeve, Attorney-in-Fact
Stock symbol
JNCE
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
3
Date filed
9/15/2021, 08:13 AM
Previous filing
Jul 19, 2021
Next filing
Jun 28, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Limited Power of Attorney